Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ds-1001b (3 trials)
taletrectinib (5 trials)
digoxin (lanoxin) (1 trial)
itraconazole (sporanox) (1 trial)
rifampin (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Neoplasms (Phase 2)
Trials (8 total)
Trial APIs (5 total)